Skip to content

Predictors of Postoperative Complications in Surgery With Pneumoperitoneum in the Trendelenburg Position

Risk Factors for Postoperative Complications in Surgery With Pneumoperitoneum in Trendelenburg Position. Observational Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06685159
Enrollment
100
Registered
2024-11-12
Start date
2024-06-19
Completion date
2026-06-19
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumoperitoneum, Trendelenburg Position

Brief summary

Evaluate early postoperative complications after surgery in Trendelenburg position with increased intraabdominal pressure (surgery with pneumoperitoneum). Evaluate the relationship between hemodynamic and metabolic changes on perioperative outcome.

Interventions

PROCEDURELaparoscopic Surgery

Laparoscopic surgery (with controlled pneumoperitoneum) in the Trendelenburg position

Sponsors

Reuven Pizov
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ASA Class I-IV. * Planned for laparoscopic surgery in the Trendelenburg position that is expected to last more than 2 hours. * Planned arterial catheter insertion.

Exclusion criteria

* Pregnancy. * Planned open abdominal surgery. * Renal Replacement Therapy.

Design outcomes

Primary

MeasureTime frameDescription
Perioperatitve change in serum syndecan-1 concentrationBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryMeasured by ELISA
Perioperatitve change in serum concentration of CannabidiolBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgery and 2h hours after completion of surgeryMeasurement of the concentration of cannabidiol (as an early marker of kidney injury) in a blood sample
Perioperatitve change in urine concentration of CannabidiolBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryMeasurement of the concentration of cannabidiol (as an early marker of kidney injury) in a urine sample taken from a Foley catheter
Perioperatitve change in TBWBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryPerioperative change in the bioimpedence-based measurement of Total Body Water (TBW)
Perioperatitve change in ECWBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryPerioperative change in the bioimpedence-based measurement of Extracellular Water (ECW)
Perioperatitve change in serum pHBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryAs measured by arterial blood gas
Perioperatitve change in serum BEBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryPerioperatitve change in serum Base Excess (BE) As measured by arterial blood gas
Perioperatitve change in serum lactate concentrationBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryPerioperatitve change in serum lactate concentration as measured by arterial blood gas
Perioperative change in urine NGALBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryMeasurement of the concentration of neutrophil gelatinase-associated lipocalin (as an early marker of kidney injury) in a urine sample taken from a Foley catheter
Acute Kidney Injury2 hours after completion of surgery; 1 day after the procedure; 3 days after the procedure.According to the KDIGO acute renal injury stage
Perioperative change in serum NGALBaseline (after anesthesia induction but before beginning of surgery) and 2h hours after completion of surgeryMeasurement of the concentration of neutrophil gelatinase-associated lipocalin (as an early marker of kidney injury) in a blood sample

Secondary

MeasureTime frameDescription
CVA / TIAWithin 30 days after surgeryNew diagnosis of cerebrovascular accident or transient ischemic attack
Myocardial IschemiaDuring hospital stay, within 30 days after surgeryNew myocardial ischemia, as diagnosed by ecg or serum troponin
ArrhythmiaDuring hospital stay, within 30 days after surgeryNew clinically significant arrhythmia
AtelectasisDuring hospital stay, within 30 days after surgeryNew atelectasis
PneumoniaDuring hospital stay, within 30 days after surgeryAccording to CDC criteria
ARDSDuring hospital stay, within 30 days after surgeryNew Acute Respiratory Distress Syndrome (ARDS) according to Berlin criteria
DeliriumWithin 7 days after surgeryAs assessed by CAM-ICU

Countries

Israel

Contacts

Primary ContactReuven Pizov, MD
pizovr@hadassah.org.il+9720506265542

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026